Virtual physical therapy service Hinge Health files for a US IPO, and reports revenue of $390M in 2024, up from $293M in 2023, and a net loss of $11.9M
The following tables set forth our summary consolidated financial data. Ashley Capoot / CNBC : Digital physical therapy provider Hinge Health files for IPO Naomi Li Gan / Tech in Asia : Digital therapy firm Hinge Health files for New York IPO Rosie Bradbury / PitchBook : Insight-backed Hinge Health, a virtual physical therapist app, files for IPO Arasu Kannagi Basil / Reuters : Hinge Health files for US IPO as healthcare listings gain momentum Dan Primack / Axios : Hinge Health files for IPO X: Dhruv Vasishtha / @dvasishtha : The Hinge Health S-1 dropped and the business looks pretty promising: - Revenue grew to $390.4 million in 2024, a 33.4% increase from $292.7 million in 2023 - Mainly the net loss significantly decreased to $11.9 million in 2024 from $108.1 million in 2023 Katie Roof / @katie_roof : Scoop confirmed, filing is here: https://www.sec.gov/... Largest Hinge Health shareholders: Insight, Atomico, 11.2 Capital, Tiger Global, Bessemer, Coatue Blake Madden / @b_madden4 : We have our first look at Hinge Health, one of the first digital health / tech-enabled services firms to go public in a hot minute (last valued privately at $6.2B in 2021). The company provides AI-enabled virtual musculoskeletal, or MSK, care to patients. Huge market given the Dhruv Vasishtha / @dvasishtha : The knock on Hinge is that it's in an extremely competitive space and hasn't really expanded beyond selling to the employer segment. At the same time payers and VBC providers are launching their own MSK plays. They're already in 1000 employers, how much more does rev scale?
Context & Ripple Effects
Hinge Health's filing follows reports that it was preparing to enter the public market and puts operating results behind a business that had previously raised $400 million at a $6.2 billion valuation in 2021, during its earlier private-funding expansion.
The key change is not merely the IPO path: revenue rose 33.4% in 2024 while the net loss narrowed sharply, giving the market a clearer test of whether employer-distributed virtual MSK care can translate growth into near-breakeven operations.
First-order effects
- Public-market investors can now assess Hinge Health against disclosed 2023-24 revenue growth and a substantially smaller loss, rather than its private-market valuation alone.
- The filing raises the accountability threshold for Hinge Health's roughly 1,000 employer deployments, as customer retention, growth efficiency, and path to profitability become central to the offering narrative.
Second-order effects
- Other virtual-care companies seeking financing or listings will face a more concrete comparison point: growth will be weighed alongside loss reduction, not simply category scale.
- Employers and health-plan buyers gain a more transparent vendor benchmark, potentially strengthening their leverage in procurement discussions with digital MSK and chronic-care providers.
Third-order effects
- If similar companies can sustain growth while reducing losses, digital health may shift from venture-funded category building toward public-market scrutiny of repeatable employer revenue and operating discipline.
- The outcome remains uncertain: a public listing can clarify which virtual-care models have durable economics, but it can also expose a wider gap between private valuations and public-market expectations.
The trend: Digital health is moving into a proving phase in which public investors are testing whether employer-focused care platforms can pair growth with credible profitability.